-
Wedbush Starts Eikon Therapeutics Inc. (EIKN) at Underperform
-
Eikon Therapeutics Opens At $17.05, IPO Priced At $18
-
Merck Is Said To Seek $30M Stake In Eikon Therapeutics IPO - Bloomberg
-
Eikon Therapeutics targets $908.2 million valuation in U.S. IPO
-
Eikon Therapeutics (EIKN) files for 17.65M share IPO at $16-$18/sh

